Skip to main content

Millipore Shareholders OK Merck KGaA Acquisition

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Millipore today said that its shareholders have voted in favor of the firm's acquisition by Germany's Merck KGaA.

The Billerica, Mass.-based research products firm said that shareholders representing around 79 percent of its shares voted, with 98 percent voting in favor of the deal.

The firm agreed to the $7.2 billion deal earlier this year, with Merck offering $107 per share in cash for all outstanding shares of Millipore. The deal was announced several days after reports had surfaced that thermo Fisher Scientific had made a $6 billion bid for Millipore.

Completion of the deal still requires clearance from US antitrust authorities. The partners hope to complete the acquisition early in the third quarter of 2010.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.